Physiologic roles of interleukin-2, interleukin-4, and interleukin-7

Current Opinion in Hematology

Volumn 3, Issue 3, 1996, Pages 230-234

  Murray, Richard ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 7;

ANIMAL MODEL; GENE TARGETING; IMMUNOPATHOLOGY; LYMPHOPOIESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0029987584     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199603030-00011     Document Type: Review

References (44)

1. Takeshita T, Asao H, Ohtani K, Ishii N, Kumaki S, Tanaka N, Munakata H, Nakamura M, Sugamura K: Cloning of the gamma chain of the human IL-2 receptor. Science 1992, 257:379-382.
2. Russell SM, Keegan AD, Harada N, Nakamura Y, Noguchi M, Leland P, Friedmann MC, Miyajima A, Pun RK, Paul WE: Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor. Science 1993, 262:1880-1883.
3. Kondo M, Takeshita T, Ishii N, Nakamura M, Watanabe S, Arai K, Sugamura K: Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science 1993, 262:1874-1877.
4. Noguchi M, Nakamura Y, Russell SM, Ziegler SF, Tsang M, Cao X, Leonard WJ: Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. Science 1993, 262:1877-1880.
5. Kimura Y, Takeshita T, Kondo M, Ishii N, Nakamura M, Van SJ, Sugamura K: Sharing of the IL-2 receptor gamma chain with the functional IL-9 receptor complex. Int Immunol 1995, 7:115-120.
6. Giri JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, Kumaki S, Namen A, Park LS, Cosman D, Anderson D: Utilization of the beta and gamma c chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 1994, 13:2822-2830.
7. Russell SM, Johnston JA, Noguchi M, Kawamura M, Bacon CM, Friedmann M, Berg M, McVicar DW, Witthuhn BA, Silvennoinen O: Interaction of IL-2r-beta and gamma(c) chains with jak1 and jak3: Implications for xscid and xcid. Science 1994, 266:1042-1045.
8. Miyazaki T, Kawahara A, Fujii H, Nakagawa Y, Minami Y, Liu ZJ, Oishi I, Silvennoinen O, Witthuhn BA, Ihle JN: Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 1994, 266:1045-1047.
9. Jenkinson EJ, Kingston R, Owen JJT: Importance of IL-2 receptors in intrathymic generation of cells expressing T cell receptors. Nature 1987, 329:160-164.
10. Schorle H, Holtschke T, Hunig T, Schimpl A, Horak I: Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 1991, 352:621-624.
11. Kundig TM, Schorle H, Bachmann MF, Hengartner H, Zinkemagel RM, Horak I: Immune responses in interleukin-2 deficient mice. Science 1993, 262:1059-1061.
12. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I: Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993, 75:253-261.
13. Ma A, Datta M, Margosian E, Chen J, Horak I: T cells, but not B cells, are •• required for bowel inflammation in interleukin-2 deficient mice. J Exp Med 1995, 182:1567-1572. To investigate the cell types involved in intestinal inflammation and anemia in interleukin-2-deficient mice, Rag-2 mutant mice (lacking T and B cells) or JH-deficient mice (lacking B cells) were bred to the interleukin-2 mutant mice. interleukin-2 by Rag-2 mutant mice are disease free, and interleukin-2 by JH mutant mice develop ulcerative colitis but not anemia.
14. Kramer S, Schimpl A, Hunig T: Immunopathology of interleukin (IL) 2-• deficient mice: thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene. J Exp Med 1995, 162:1769-1776. Interleukin-2-deficient mice were bred to athymic nu/nu mice. The double mutant mice do not develop ulcerative colitis, showing the dependence on thymic-derived T cells for this disease. Additionally, cell transfer experiments show that the abnormal interleukin-2-deficient thymic-dependent cells (that cause disease) can be controlled by normal thymus-derived but not thymus-independent T cells in mixed chimeras.
15. Kneitz B, Herrmann T, Yonehara S, Schimpl A: Normal clonal expansion • but Impaired fas-mediated cell-death and energy induction in interleukin-2-deficient mice. Eur J Immunol 1995, 25:2572-2577. To investigate the basis for the intestinal immunopathology in interleukin-2-deficient animals, T cells were stimulated with superantigens. Activation proceeds normally, but deletion or the generation of anergy was impaired. Although Fas expression appears normal, the superantigen-stimulated cells do not apoptose in the presence of anti-Fas antibodies.
16. Sadlack B, Lohler J, Schorle H, Klebb G, Haber H, Sickel E, Neolle RJ, • Horak I: Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation in CD4 (+) T cells. Eur J Immunol 1995, 25:3053-3059. The lymphoproliferative disorder in interleukin-2-deficient animals was investigated by inhibiting T cells in vivo with an antibody to the CD40 ligand. This treatment prevented the disease and indicated that inhibiting other stimulatory molecules on the T cell does not allow these hyperreactive cells to cause disease.
17. Lenardo MJ: Interleukin-2 programs mouse α/β T-lymphocytes for apoptosis. Nature 1991, 353:858-861.
18. Paul WE, Ohara J: B-cell stimulatory factor-1/interleukin 4. Ann Rev Immunol 1987, 5:429-459.
19. Finkelman FD, Holmes J, Katona IM, Urban JF, Backmann MP, Park LS, Schooley KA, Coffman RL, Mosmann TR, Paul WS: Lymphokine control of in vivo immunoglobulin isotype selection. Ann Rev Immunol 1990, 8:303-333.
20. Carding SR, Mayday AC, Bottomly K: Cytoklnes in T cell development Immunol Today 1991, 12:239-245.
21. Kuhn R, Rajewsky K, Muller W: Generation and analysis of interleukin-4 deficient mice. Science 1991, 254:707-710.
22. Mosmann TR, Coffman RL: Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 1989, 7:145-173.
23. Kopf M, Le Gros G, Bachman M, Lamers MC, Bluethmann H, Kolher G: Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 1993, 366:339-342.
24. Lawrence RA, Allen JE, Gregory WF, Kopf M, Maizels RM: Infection of IL-4-deficient mice with the parasitic nematode Brugla malayi demonstrates that host resistance is not dependent on a T helper 2-dominated immune response. J Immunol 1995, 154:5995-6001.
25. von der Weid T, Kopf M, Kohler G, Langhome J: The immune response to Plasmodium chabaudi malaria in interleukin-4-deficient mice. Eur J Immunol 1994, 24:2285-2293.
26. Coffman RL, Seymour BW, Hudak S, Jackson J, Rennick D: Antibody to interleukin-5 inhibits helmlnth-induced eosinophilia in mice. Science 1989, 245:308-310.
27. Nishinakamura R, Nakayama N, Hirabayashi Y, Inoue T, Aud D, McNeil T, Azuma S, Yoshida S, Toyoda Y, Arai K, Mijajima A, Murray R: Mice deficient for the IL-3/GM-CSF/IL-5 receptor exhibit lung pathology and impaired immune response. Immunity 1995, 2:211-222.
28. Brusselle G, Kips J, Joos G, Bluethmann H, Pauwels R: Allergen-induced • airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice. Am J Respir Cell Mol Biol 1995, 12:254-259. This work extends studies of the importance of interleukin-4 early in Th2 responses. Airway inflammation and hyperresponsiveness were shown to be dependent on interleukin-4.
29. Vajdy M, Kosco-Vilbois MH, Kopf M, Kohler G, Lycke N: Impaired mucos•• al immune responses in interleukin-4 gene targeted mice. J Exp Med 1995, 181:41-54. Mucosal immunization, using a potent adjuvant, was diminished or absent in interleukin-4-deficient mice. Neither B cells nor T cells respond well to the mucosal immunization, but interestingly, both respond normally to systemic challenge. The poor mucosal response also correlated with an inability to form germinal centers in Peyer's patches.
30. Sadlack B, Kuhn R, Schorle H, Rajewsky K, Muller W, Horak I: Development and proliferation of lymphocytes in mice deficient for both interleukins-2 and -4. Eur J Immunol 1994, 24:281-284.
31. Noguchi M, Yi H, Rosenblatt HM, Filipovich AH, Adelstein S, Modi WS, McBride OW, Leonard WJ: Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 1993, 73:147-157.
32. von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SE, Murray •• R: Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 1995, 181:1519-1526. Defines interleukin-7 as a uniquely important cylokine for T- and B-cell development and expansion. Blood and splenic T and B cells are markedly reduced, as are thymocytes. B lymphopoiesis is blocked at the transition of pro-B to pre-B cells in the bone marrow. In general, the remaining lymphocytes show normal cell surface phenotypes, indicating some level of interleukin-7-independent development. Additionally, as this mutation is not intrinsic to the lymphocytes themselves but to the microenvironment, the remaining lymphocytes are capable of stimulation by mitogens and cytokines.
33. DiSanto JP, Muller W, Guy-Grand D, Fischer A, Rajewsky K: Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc Natl Acad Sci U S A 1995, 92:377-381. Mutation of the γc receptor removes the capacity of lymphocytes to respond to a number of cytokines. Mutant mice have reduced peripheral lymphocytes, a more extreme reduction of natural killer cells, and severely diminished gut-associated intraepithelial lymphocytes.
34. + T cells, and inflammatory bowel lesions.
35. Grabstein KH, Waldschmidt TJ, Finkelman FD, Hess BW, Alpert AR, Boiani NE, Namen AE, Morrissey PJ: Inhibition of murine B and T lymphopoiesis in vivo by an anti-interleukin 7 monoclonal antibody. J Exp Med 1993, 178:257-264.
36. Sudo T, Nishikawa S, Ohno N, Akiyama N, Tamakoshi M, Yoshida H, Nishikawa S: Expression and function of the interleukin 7 receptor in murine lymphocytes. Proc Natl Acad Sci U S A 1993, 90:9125-9129.
37. Thomis DC, Gurniak CB, Tivol E Sharpe AH, Berg LU: Defects in B lym• phocyte maturation and T lymphocyte activation in mice lacking Jak3. Science 1995, 270:794-797. Molecules downstream of the γc receptor complex, such as the Jak family of kinases, are involved in transduction of signals into cells. Jak 3-deficient mice show abnormalities in lymphocyte development that indicate the importance of interleukin-7/γc/Jak 3 interaction.
38. Nosaka T, van Deursen JMA, Tripp RA, Thierfelder WE, Witthuhn BA, McMickle AP, Doherty PC, Grosveld GC, Ihle JE: Defective lymphoid development in mice lacking Jak3. Science 1995, 270:800-802. An independently generated Jak 3-deficient mouse indicates the function of signal transduction molecules downstream of the γc receptor complexes.
39. Peschon JJ, Morrissey PJ, Grabstein KH, Ramsdell FJ, Maraskovsky E, Gliniak BC, Park LS, Ziegler SF, Williams DE, Ware CB, Meyer JD, Davidson BL: Early lymphocyte expansion is severely impaired in interleukin-7 receptor-deficient mice. J Exp Med 1994, 180:1955-1960. The interleukin-7 receptor binds at least two ligands, interleukin-7 and TSLP. Interleukin-7 receptor-deficient animals show many similarities to interleukin-7 ligand-deficient or γc receptor-deficient animals. However, some of the interleukin-7 receptor mutants show a more severely hypocellular thymus, indicating that other molecules interacting through the interleukin-7 receptor may be playing a role in development at stages earlier than interleukin-7. However, it is unclear why only some of the mutant animals exhibit this phenotype.
40. Namen AE, Schmierer AE, March CJ, Overell RW, Park LS, Urdal DL, Mochizuki DY: B cell precursor growth-promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors. J Exp Med 1988, 167:988-1002.
41. Namen AE, Lupton S, Hjerrild K, Wignall J, Mochizuki DY, Schmierer A, Mosley B, March CJ, Urdal D, Gillis S: Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature 1988, 333:571-573.
42. Lin JX, Migone TS, Tsang M, Friedmann M, Weatherbee JA, Zhou L, • Yamauchi A, Bloom ET, Mietz J, John S, Leonard WJ: The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 1995, 2:331-339. Cytokine/receptor-induced signal transduction proceeds to activation of transcription factors, such as the STAT molecules. This study compares the similarities and differences of activation of the STAT family of transcnption factors by interleukin-2, interleukin-4, interleukin-7, interleukin-9, and interleukin-15.
43. Hou J, Schindler U, Henzel WJ, Ho TC, Brasseur M, McKnight SL: An interleukin-4-induced transcription factor: IL-4 Stat. Science 1994, 265:1701-1706.
44. Grzegorzewski KJ, Komschlies KL, Jacobsen SEW, Ruscetti FW. Keller JR, Wiltrout RH: Mobilization of long term reconstituting hematopoietic stem cells in mice by recombinant human interleukin-7. J Exp Med 1995, 181:369-374.